Highest benefit of neoadjuvant nivolumab in breast tumours with high PD-L1 expression and/or low ER expression Presented ByDr Sherene Loi, Peter MacCallum Cancer Centre, Australia TrialPhase 3, CheckMate 7FL ConferenceSABCS 2023 11 January, 2024 15:02